Cannabinoids have excited researchers for years. They are a group of unique chemicals produced by cannabis, and studies have shown that they have a diverse range of medicinal properties. The most famous one, THC (delta-9 tetrahydrocannabinol), creates the psychoactive high marijuana is famous for. Cannabidiol is another major cannabinoid, and unlike THC, isn’t psychoactive.
CBD is said to be effective against a variety of conditions ranging from high blood pressure and anxiety to chronic pain and insomnia. However, there’s little scientific evidence to back these claims, and while scientists agree that cannabidiol and cannabinoids, in general, have medicinal properties, more research is needed.
Colorado State University (CSU) will soon be among the pioneers in cannabinoid research after an alumna donated funds to the university to start a research center dedicated to studying cannabinoids.
According to the lab’s research director, Dr. Melissa Reynolds, the center located in the College of Natural Resources on CSU’s Fort Collins campus is developing an analytical research lab that will allow researchers to identify and study various types of cannabinoids in order to determine what they could be used for as well as the best ways to formulate them into products.
“The college is always interested in looking for additional areas of strength that we can add to our research programs, or identifying ongoing research that’s currently happening within CSU and figuring out a way that we can continue to support and grow those areas. Additionally, we have a lot of alumni that are very supportive, even after graduating and are wanting to see CSU grow and flourish in different areas.”
“One of those particular alumni was Leslie Buttorff. She was interested in establishing a research center related to cannabinoid research that would give opportunities for undergraduates, graduate students, researchers, faculty and others to really explore a fairly unexplored space right now in cannabinoid research,” says Reynolds.
Buttorff’s $1.5 million donation will help build the instrumentation in the lab as well as cover additional facility development and operating costs. According to Reynolds, it will establish CSU as the leader in cannabinoid research as well as providing a unique industry partnership.
“There will be research funded there, but the initial donation is also really focused on establishing the center with state of the art, high-tech equipment that can be used to get answers to some of the questions that researchers are interested in asking,” she says.
Analysts believe that cannabidiol companies, such as SinglePoint Inc. (OTCQB: SING), welcome the interest of academic institution in studying cannabis and its compounds since such research will help the industry to grow in a science-led way.
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.